evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract,articles/13/pmid,articles/13/title,articles/13/journal,articles/13/pubDate,articles/13/volume,articles/13/issue,articles/13/pages,articles/13/authors,articles/13/elocationId,articles/13/link,articles/13/reference,articles/13/abstract,articles/14/pmid,articles/14/title,articles/14/journal,articles/14/pubDate,articles/14/volume,articles/14/issue,articles/14/pages,articles/14/authors,articles/14/elocationId,articles/14/link,articles/14/reference,articles/14/abstract,articles/15/pmid,articles/15/title,articles/15/journal,articles/15/pubDate,articles/15/volume,articles/15/issue,articles/15/pages,articles/15/authors,articles/15/elocationId,articles/15/link,articles/15/reference,articles/15/abstract,articles/16/pmid,articles/16/title,articles/16/journal,articles/16/pubDate,articles/16/volume,articles/16/issue,articles/16/pages,articles/16/authors,articles/16/elocationId,articles/16/link,articles/16/reference,articles/16/abstract
18483,GENE_SUMMARY,,SMAD3 encodes a tumor suppressor and transcription factor that is a downstream effector in the TGF-ß signal transduction pathway. SMAD3 is infrequently mutated in a diverse range of cancers.,,2017-04-07,,4088,SMAD3,SMAD family member 3,False,ENST00000327367,NM_005902.3,MADH3,LDS1C,HSPC193,LDS3,HsT17436,JV15-2,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
18484,GENE_BACKGROUND,,"The SMAD3 (SMAD family member 3) gene encodes a transcriptional effector in the transforming growth factor beta (TGFß) signal transduction pathway (PMID: 25935112). Members in the SMAD family of proteins have an N-terminal MH1 and a C-terminal MH2 domain, the former important for DNA binding and the latter for binding to regulators and effectors, including the TGFß receptors and transcription cofactors (PMID: 12821112, 25935112). Along with SMADs 1,2,5,8/9, SMAD3 is classified as a receptor-regulated-SMAD (R-SMAD) for which activation requires the phosphorylation of two serine residues in the MH2 domain by a membrane receptor serine kinase. In the case of SMAD2 and SMAD3, activation is mediated by the binding of the TGFß superfamily of cytokines (e.g. TGFß1, TGFß2, TGFß3, activin and nodal) to receptor kinases (PMID: 25935112, 9759503). Phosphorylation allows SMAD3 to form a heterotrimer together with another R-SMAD and SMAD4 which functions to induce target gene expression (PMID: 25935112). The specificity of TGFß target gene expression depends on the availability of transcriptional co-activators and chromatin accessibility (PMID: 22992590). The contextual nature TGFß-dependent transcription allows the TGFß pathway to suppress tumorigenesis in premalignant states and promote invasiveness and metastasis during cancer progression (PMID: 22992590, 18662538, 20495575, 21217753, 21778426, 22167769). SMAD3 mutations are found in hereditary syndromes in the Loeys-Dietz phenotypic series of diseases (PMID: 22167769, 21217753, 21778426). Deregulation of TGFß signaling is a common feature of colorectal cancer, which may occur via loss-of-function mutations and focal deletion of SMAD3, in accordance with studies in transgenic mice (PMID: 22810696, 23139211, 9753318, 16959974). SMAD3 alterations, although infrequent, have been observed in various other tumor types (PMID: 16959974, 14647420, 21771027, 15295048, 12161532).",,2017-04-07,,4088,SMAD3,SMAD family member 3,False,ENST00000327367,NM_005902.3,MADH3,LDS1C,HSPC193,LDS3,HsT17436,JV15-2,True,21778426,Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms.,Circulation research,2018-09-02T20:11:00,109,6,680-6,Regalado ES et al,doi: 10.1161/CIRCRESAHA.111.248161,,0001-09-02,,9753318,Smad3 mutant mice develop metastatic colorectal cancer.,Cell,0001-09-18,94,6,703-14,Zhu Y et al,,,0001-09-18,,21217753,Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis.,Nature genetics,2018-02-01T20:11:00,43,2,121-6,van de Laar IM et al,doi: 10.1038/ng.744,,0001-02-01,,22810696,Comprehensive molecular characterization of human colon and rectal cancer.,Nature,2018-07-18T20:12:00,487,7407,330-7,Cancer Genome Atlas Network.,doi: 10.1038/nature11252,,0001-07-18,,21771027,Expression and clinical significance of the transforming growth factor-β signalling pathway in endometrial cancer.,Histopathology,2018-07-01T20:11:00,59,True,63-72,Mhawech-Fauceglia P et al,doi: 10.1111/j.1365-2559.2011.03892.x,,0001-07-01,,22992590,TGFβ signalling in context.,Nature reviews. Molecular cell biology,2018-10-01T20:12:00,13,10,616-30,Massagué J,doi: 10.1038/nrm3434,,0001-10-01,,25935112,Structural determinants of Smad function in TGF-β signaling.,Trends in biochemical sciences,2018-06-01T20:15:00,40,6,296-308,Macias MJ et al,doi: 10.1016/j.tibs.2015.03.012,,2018-06-01T03:08:00,,22167769,Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome.,Journal of medical genetics,2018-01-01T20:12:00,49,True,47-57,van de Laar IM et al,doi: 10.1136/jmedgenet-2011-100382,,0001-01-01,,16959974,The consensus coding sequences of human breast and colorectal cancers.,"Science (New York, N.Y.)",2018-10-13T20:06:00,314,5797,268-74,Sjöblom T et al,,,0001-10-13,,12161532,"Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-beta and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumors.",The Journal of clinical endocrinology and metabolism,2018-08-01T20:02:00,87,8,3911-4,Shattuck TM et al,,,0001-08-01,,9759503,TGF-beta signal transduction.,Annual review of biochemistry,1998,67,,753-91,Massagué J,,,Massagué J. Annual review of biochemistry. 1998;67()753-91.,,18662538,TGFbeta in Cancer.,Cell,2018-07-25T20:08:00,134,2,215-30,Massagué J,doi: 10.1016/j.cell.2008.07.001,,0001-07-25,,20495575,TGFbeta signalling: a complex web in cancer progression.,Nature reviews. Cancer,2018-06-01T20:10:00,10,6,415-24,Ikushima H et al,doi: 10.1038/nrc2853,,0001-06-01,,14647420,Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer.,Oncogene,2018-02-19T20:04:00,23,7,1333-41,Han SU et al,,,0001-02-19,,12821112,Role of Smad4 (DPC4) inactivation in human cancer.,Biochemical and biophysical research communications,2018-07-11T20:03:00,306,4,799-804,Miyaki M et al,,,2018-07-11T08:04:00,,15295048,Loss of Smad3 in acute T-cell lymphoblastic leukemia.,The New England journal of medicine,2018-08-05T20:04:00,351,6,552-9,Wolfraim LA et al,,,0001-08-05,,23139211,"SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer.",Cancer research,2018-01-15T20:13:00,73,2,725-35,Fleming NI et al,doi: 10.1158/0008-5472.CAN-12-2706,,0001-01-15,
